In November 2021, the World Economic Forum established disease-diagnosing breath sensors and wireless biomarker devices as two of the Top 10 Emerging Technologies of 2021, selected considering their disruption and attractiveness to investors and researchers with promising major benefits to societies and economies. The proposed SMARTMASK4CF addresses hot topics namely breathsensors, wireless biomarker devices, rare diseases, and paper-based sustainable sensors having the overriding goal to develop paper-based breath (bio)sensors integrated in the face mask combined with wireless readers for sustainable monitoring tools in cystic fibrosis (CF) disease. Especially, dedicated to patients affected by lung diseases due to Pseudomonas aeruginosa infection, which can be considered as the main cause of morbidity and mortality in patients with CF. SMARTMASK4CF encompasses a flower-like paper-based tool embedded with N95 mask for sampling the exhaled breath aerosol and combined with multiple paper-based colorimetric/electrochemical (bio)sensors for targeted analysis of the selected biomarkers in exhaled breath aerosol.
The presence of a clinician expert in CF disease as a national collaborator and the relevant international scientists with expertise in the topic of the project will boost the SMARTMASK4CF project to reach the ambitious goals thanks to the different skills of the SMARTMASK4CF consortium. The SMARTMASK4CF project aims to: